Clinical study on 2 types of intrauterine stents with different thickness and hardness in the treatment of moderate-to-severe intrauterine adhesions.
10.11817/j.issn.1672-7347.2022.220340
- Author:
Huan HUANG
1
;
Xuetao MAO
2
;
Yang YU
3
;
Bingxin XIAO
3
;
Xingping ZHAO
3
;
Aiqian ZHANG
4
;
Dabao XU
5
Author Information
1. Department of Gynecology, Third Xiangya Hospital, Central South University, Changsha 410013, China. huanghuan90528@163.com.
2. Department of Gynecology, Third Xiangya Hospital, Central South University, Changsha 410013, China. formxt@163.com.
3. Department of Gynecology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
4. Department of Gynecology, Third Xiangya Hospital, Central South University, Changsha 410013, China. Zhangaiqian1112@126.com.
5. Department of Gynecology, Third Xiangya Hospital, Central South University, Changsha 410013, China. dabaoxu2022@163.com.
- Publication Type:Journal Article
- Keywords:
hysteroscopic adhesiolysis;
intrauterine adhesions;
intrauterine stent
- MeSH:
Humans;
Retrospective Studies;
Tissue Adhesions;
Uterus/pathology*
- From:
Journal of Central South University(Medical Sciences)
2022;47(11):1575-1585
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Although hysteroscopic adhesiolysis (HA) is the main treatment for intrauterine adhesion (IUA), postoperative management of IUA remains challenging because there is no consensus on how to mitigate the high rate of postoperative adhesions reformation. This study aims to compare the effectiveness and safety of 2 types of intrauterine stents with different thickness and hardness in treating moderate-to-severe IUA.
METHODS:A retrospective clinical study was conducted in the Third Xiangya Hospital of Central South University from November 2020 to July 2021. A total of 191 patients with moderate-to-severe IUA who received surgical treatment and placed intrauterine stents after HA to prevent recurrence of postoperative adhesions were included. According to the hardness and thickness of the intrauterine stents, the participants were divided into a case group (placed the novel thin intrauterine stent, n=62) and a control group (placed the conventional stent, n=129). After 2-3 menstrual cycles, a second-look hysteroscopy was performed, and the intrauterine stents were removed. The postoperative efficacy [the reduction of American Fertility Society (AFS) scores, the adhesions reformation rate, the changes in menstrual pattern, and the pregnancy rate during the follow-up], safety (the adverse events), and applicability (the difficulty of stent removal) were compared between the 2 groups.
RESULTS:No significant differences in preoperative clinical characteristics were observed between the 2 groups (all P>0.05). The menstrual volume of all patients was increased after the treatment. The reduction of AFS scores and the menstruation recovery rate were not significantly different between the 2 groups (P=0.519 and P=0.272, respectively). Notably, there was no case of displacement in the case group, while the displacement rate of the control group was 2.3% (P=0.552). Moreover, there was no significant difference in abdominal pain or postoperative abnormal vaginal bleeding between the 2 groups (P=0.823 and P=0.851, respectively). However, the difficulty rate of removing the thinner stents was significantly lower than that of removing the traditional stent (21.0% vs 38.8%, P=0.014). During the follow-up for half a year of the postoperative period, the pregnancy rate did not differ significantly in the case and control groups (45.0% vs 34.6%, P=0.173).
CONCLUSIONS:The novel intrauterine stent shows noninferior efficacy and had a good safety profile compared with conventional stents in treating moderate-to-severe IUA. Importantly, it was more convenient to be removed without increasing the rate of displacement and detachment. Therefore, it could reduce the amount of damage to the endometrium and has higher applicability than conventional stents.
